Will oral contraceptives join SSRIs as a first-line treatment option for women with premenstrual dysphoric disorder?

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.2, 2006-03, pp. : 183-185

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of premenstrual dysphoric disorder

By Rapkin Andrea J Lewis Erin I

Women's Health, Vol. 9, Iss. 6, 2013-11 ,pp. : 537-556

Future Medicine

Access to resources Recommend Favorite

Paroxetine use in the treatment of premenstrual dysphoric disorder

By Misri Shaila Kendrick Kristin

Women's Health, Vol. 2, Iss. 1, 2006-01 ,pp. : 43-51

Future Medicine

Access to resources Recommend Favorite

Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder

By Rapkin Andrea J McDonald Michelle Winer Sharon A

Women's Health, Vol. 3, Iss. 4, 2007-07 ,pp. : 395-408

Future Medicine

Access to resources Recommend Favorite

Premenstrual Dysphoric Disorder: A Critical Review of Its Phenomenology, Etiology, Treatment and Clinical Status

Current Women's Health Reviews, Vol. 14, Iss. 1, 2018-01 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

By Montoya Alonso Hervas Amaia Cardo Esther Artigas Josep Mardomingo María J. Alda José A. Gastaminza Xavier García-Polavieja María J. Gilaberte Inmaculada Escobar Rodrigo

Current Medical Research and Opinion, Vol. 25, Iss. 11, 2009-11 ,pp. : 2745-2754

Informa Healthcare

Access to resources Recommend Favorite